Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Optison
Optison is an ultrasound contrast agent composed of microbubbles of octafluoropropane gas encapsulated within a protein shell. It is administered intravenously to enhance the visualization of blood flow and tissue perfusion during ultrasound examinations, particularly in echocardiography. The microbubbles resonate and scatter ultrasound waves, creating a stronger signal return from the blood pool, thereby improving image clarity and diagnostic accuracy.
For enhancing ultrasound images of the heart, liver, and other organs to aid in the diagnosis of various conditions.
Outcome:
May increase the risk of severe cardiopulmonary reactions.
Mechanism:
Both agents can affect respiratory and cardiac function.
Outcome:
May increase the risk of serious cardiovascular events.
Mechanism:
Both agents can affect heart function.
Outcome:
No known significant interaction.
Mechanism:
Similar mechanism of action but different formulations.
Most likely new formulation: Targeted microbubbles for specific disease imaging (Year: 2026, 70% confidence)
Based on current usage patterns and emerging diagnostic trends, Optison's market share is predicted to remain stable with a 2% projected growth over the next 5 years.
Ultrasound Contrast Agent
Perfluorocarbon